5 Big Stocks That Are Expected to Outperform Apple

> Expected upside: 23%
> Market cap: $27 billion

Illumina was just trading at $186.25, so the consensus price target of $229.88 leaves implied upside of 23.4%. This company is far less known by the public that invests in biotech and advanced health care technology. It develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation — and it is the leader in gene sequencing technology. Illumina’s CEO even recently said the market could be a $20 billion one, and the stock also recently was named as one of three top stocks to buy after delivering great earnings. Still, shares have pulled back a bit.

Shares of Illumina have traded in a range of $131.07 to $213.33 in the past year. The highest analyst price target is actually all the way up at $270, which implies upside of 45%, if the most aggressive analyst is proven right in the year or more ahead. Illumina shares are up 39% from this time a year earlier.

ALSO READ: The Next 2 Biotech Buyout Candidates

Micron Technology
> Expected upside: 38%
> Market cap: $30 billion

With shares trading near $28.30, the consensus analyst price target of $39.03 would leave implied upside of 37.9%. The company has grown in flash memory and is considered the king of DRAM. While Micron may no longer have massive growth after the turnaround, its pullback from the peak in the mid-$30s seems to have stabilized close to $27 in October and in March. Now analysts and investors are trying to get used to valuing Micron like a value stock. While earnings growth has stalled, this stock trades at less than 10 times expected earnings now.

The 52-week trading range is $25.25 to $36.59. Micron shares may have pulled back, but the share price is still up about 15% from a year ago. The highest analyst price target is still all the way up at $50, which would leave what seems a hard to believe 76% or so, if that actually comes about.

> Expected upside: 33%
> Market cap: $6 billion

SolarCity now trades at about $61.00. A consensus price target of $81.00 would leave implied upside of 32.8%. This is the king of rooftop solar installations in America. It also has ties to Elon Musk of Tesla. Despite low oil and energy prices, the company’s stock sell-off from over $70 that first went under $50 was all from last September and October. Its stock had been range-bound since then, and now shares are trying to break out, if that area above $60 can hold. What hurts about evaluating SolarCity is that it is expected to keep losing money for some time. Still, revenue expectations of $765 million by the end of 2016 would be after 78% revenue growth in 2016 and 68% growth in 2015.

SolarCity shares have traded within a 52-week range of $45.79 to $79.40. They are up 16% from a year ago. The highest price target from analysts was all the way up at $98, which implied an upside of over 60%, if the most aggressive target actually manages to come to fruition.

ALSO READ: Why Starbucks Could Rise 20% More

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.